Addressing Challenges to Alternative Payment Models for New Alzheimer’s Disease Therapies for US Commercial Payers is a research paper published in PharmacoEconomics (2022). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute on Aging
Grant: R01AG060165
National Institute on Aging
Grant: R01AG062277
National Institutes of Health
Grant: 1Z01BB001002-16
ANALYSIS AND CHARACTERIZATION OF ALUMINUM ADJUVANT IN INJECTABLES
National Institutes of Health
Grant: 5R01AG060165-04
Assessing Diagnosis and Treatment Delays and Health Care Disparities by Race/Ethnicity among Individuals with Alzheimer’s Disease and Related Dementias
National Institutes of Health
Grant: 5R01AG062277-04
Ensuring Access to Novel Alzheimer’s and Dementia Treatments: Evaluating Innovative Payment Approaches
Fields of Study
MeSH Terms
Keywords